86 related articles for article (PubMed ID: 9191622)
21. Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study.
Brevetti G; Perna S; Sabbà C; Rossini A; Scotto di Uccio V; Berardi E; Godi L
Eur Heart J; 1992 Feb; 13(2):251-5. PubMed ID: 1555624
[TBL] [Abstract][Full Text] [Related]
22. A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication.
Brass EP; Koster D; Hiatt WR; Amato A
Vasc Med; 2013 Feb; 18(1):3-12. PubMed ID: 23321261
[TBL] [Abstract][Full Text] [Related]
23. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
Angiology; 2002; 53 Suppl 1():S13-7. PubMed ID: 11865829
[TBL] [Abstract][Full Text] [Related]
24. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
Messa GL; Gelso E
Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
[TBL] [Abstract][Full Text] [Related]
25. Treatment of intermittent claudication.
Tyson VC
Practitioner; 1979 Jul; 223(1333):121-6. PubMed ID: 482241
[No Abstract] [Full Text] [Related]
26. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease.
Mohler ER; Hiatt WR; Creager MA
Circulation; 2003 Sep; 108(12):1481-6. PubMed ID: 12952839
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of chronic arterial occlusive disease of the lower limbs with propionyl-1-carnitine in elderly patients].
Terranova R; Luca S
Minerva Med; 2001 Feb; 92(1):61-6. PubMed ID: 11317141
[TBL] [Abstract][Full Text] [Related]
28. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
Kakkos SK; Geroulakos G; Nicolaides AN
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the therapeutic efficacy and tolerability of levocarnitine propionyl in the treatment of chronic obstructive arteriopathies of the lower extremities: a multicentre controlled study vs. placebo.
Coto V; D'Alessandro L; Grattarola G; Imparato L; Lingetti M; Mancini M; Nolfe G; Rengo F
Drugs Exp Clin Res; 1992; 18(1):29-36. PubMed ID: 1600865
[TBL] [Abstract][Full Text] [Related]
30. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
Collins EG; Edwin Langbein W; Orebaugh C; Bammert C; Hanson K; Reda D; Edwards LC; Littooy FN
Med Sci Sports Exerc; 2003 Mar; 35(3):384-93. PubMed ID: 12618567
[TBL] [Abstract][Full Text] [Related]
31. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
Angiology; 2002; 53 Suppl 1():S7-12. PubMed ID: 11865838
[TBL] [Abstract][Full Text] [Related]
32. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.
Grossman PM; Mendelsohn F; Henry TD; Hermiller JB; Litt M; Saucedo JF; Weiss RJ; Kandzari DE; Kleiman N; Anderson RD; Gottlieb D; Karlsberg R; Snell J; Rocha-Singh K
Am Heart J; 2007 May; 153(5):874-80. PubMed ID: 17452167
[TBL] [Abstract][Full Text] [Related]
33. The effects of sublingual glyceryl trinitrate on walking distance in patients with intermittent claudication. A randomised, doubled-blind, placebo-controlled, cross-over study.
Heer R; Walker S; MacSweeney S
Curr Med Res Opin; 2001; 17(2):113-5. PubMed ID: 11759179
[TBL] [Abstract][Full Text] [Related]
34. Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study.
Brevetti G; Chiariello M; Ferulano G; Policicchio A; Nevola E; Rossini A; Attisano T; Ambrosio G; Siliprandi N; Angelini C
Circulation; 1988 Apr; 77(4):767-73. PubMed ID: 3280157
[TBL] [Abstract][Full Text] [Related]
35. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study.
Ciacci C; Peluso G; Iannoni E; Siniscalchi M; Iovino P; Rispo A; Tortora R; Bucci C; Zingone F; Margarucci S; Calvani M
Dig Liver Dis; 2007 Oct; 39(10):922-8. PubMed ID: 17693145
[TBL] [Abstract][Full Text] [Related]
36. Effects of policosanol (10 mg/d) versus aspirin (100 mg/d) in patients with intermittent claudication: a 10-week, randomized, comparative study.
Illnait J; Castaño G; Alvarez E; Fernández L; Mas R; Mendoza S; Gamez R
Angiology; 2008; 59(3):269-77. PubMed ID: 18388038
[TBL] [Abstract][Full Text] [Related]
37. Treatment of severe intermittent claudication with pentoxifylline: a 40-week, controlled, randomized trial.
Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; De Sanctis MT; Incandela L; Geroulakos G; Ramaswami G; Cazaubon M; Barsotti A; Vasdekis S; Bavera P; Ippolito E
Angiology; 2002; 53 Suppl 1():S1-5. PubMed ID: 11865828
[TBL] [Abstract][Full Text] [Related]
38. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
[TBL] [Abstract][Full Text] [Related]
39. The PADHOC device is a better guide to the actual incapacity suffered by claudicants than the gold standard constant load treadmill test.
Coughlin PA; Kent PJ; Berridge DC; Scott DJ; Kester RC
Eur J Vasc Endovasc Surg; 2006 Dec; 32(6):651-6. PubMed ID: 16679038
[TBL] [Abstract][Full Text] [Related]
40. Assessing the validity and responsiveness of disease-specific quality of life instruments in intermittent claudication.
Mehta T; Venkata Subramaniam A; Chetter I; McCollum P
Eur J Vasc Endovasc Surg; 2006 Jan; 31(1):46-52. PubMed ID: 16226903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
